Home›Research›Compare›CJC-1295 vs Ipamorelin
Peptide ComparisonCJC-1295 vs Ipamorelin
Both are GH / IGF Axis peptides.
CJC-1295
CJC-1295 DAC
Half-life: 6–8 days (DAC form)
445 providers listed
Ipamorelin
NNC 26-0161
Half-life: 2 hours
464 providers listed
CJC-1295 has a longer half-life than Ipamorelin, so it generally needs less frequent dosing.
CJC-1295
Evidence
Half-life
6–8 days (DAC form)
Ipamorelin
Evidence
Half-life
2 hours
| Your goal | Better option |
|---|---|
| Extended GH elevation via longer half-life | CJC-1295 |
| Fewer injections needed per week (DAC variant) | CJC-1295 |
| More selective GH pulse (minimal cortisol/prolactin impact in research) | Ipamorelin |
| GHRP mechanism — different pathway from GHRH analogs | Ipamorelin |
| More provider options (445 vs 464) | Ipamorelin |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
CJC-1295
Ipamorelin
CJC-1295
Ipamorelin
Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications…
Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Imp…
Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the managem…
About CJC-1295
CJC-1295 binds to and activates pituitary GHRH receptors, stimulating pulsatile GH secretion. The DAC modification enables covalent binding to albumin, dramatically extending the active peptide half-life. This sustained GH pulse pattern is intended to mimic physiological GH release more closely than shorter-acting GHRH analogues.
About Ipamorelin
Ipamorelin binds to the ghrelin receptor (GHSR-1a) and stimulates dose-dependent GH release with a clean hormonal profile. Unlike GHRP-6 or hexarelin, it does not significantly stimulate appetite-related pathways or cortisol secretion at standard research doses. This selectivity makes it a frequently studied peptide for protocols where hormonal side-effect profiles are a consideration.
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
CJC-1295
Research protocols routinely measure IGF-1 to track GH axis activity before and during use. Fasting glucose and insulin are monitored because GH elevation can reduce insulin sensitivity over time.
Ipamorelin
Research protocols routinely measure IGF-1 to track GH axis activity before and during use. Fasting glucose and insulin are monitored because GH elevation can reduce insulin sensitivity over time.
Commonly stacked
Well DocumentedCJC-1295 and Ipamorelin are reported to work together. Research suggests Ipamorelin and CJC-1295 may produce enhanced growth hormone release effects when combined. CJC-1295 provides sustained GHRH receptor stimulation while Ipamorelin provides pulsatile ghrelin receptor stimulation — complementary pathways studied in GH secretion research.
CJC-1295
Ipamorelin
Research suggests Ipamorelin and CJC-1295 may produce enhanced growth hormone release effects when combined. CJC-1295 provides sustained GHRH receptor stimulation while Ipamorelin provides pulsatile ghrelin receptor stimulation — complementary pathways studied in GH secretion research.
GLP-1 agonists
Research notes metabolic pathway overlap between growth hormone-releasing peptides and GLP-1 agonists. Both compound classes influence metabolic signaling; limited research has studied their combined effects. Consult your prescriber before combining.
Ipamorelin
CJC-1295
Research suggests Ipamorelin and CJC-1295 may produce enhanced growth hormone release effects when combined. CJC-1295 provides sustained GHRH receptor stimulation while Ipamorelin provides pulsatile ghrelin receptor stimulation — complementary pathways studied in GH secretion research.
Mod GRF 1-29
Research suggests Ipamorelin and Mod GRF 1-29 may produce enhanced growth hormone pulse effects when combined. Ipamorelin acts via ghrelin receptors (GHSR) while Mod GRF 1-29 acts via GHRH receptors — distinct pathways that research suggests may amplify GH secretion when activated together.
Sermorelin
Research suggests Sermorelin and Ipamorelin may produce complementary growth hormone release effects when combined. Sermorelin acts as a GHRH analogue via pituitary receptors, while Ipamorelin acts via ghrelin receptors — dual-pathway stimulation studied in GH optimization research.
CJC-1295
Ipamorelin
Where to source these peptides
CJC-1295
445 listed
Browse directory →
Providers offeringIpamorelin
464 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More GH / IGF Axis Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 4, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). CJC-1295 vs Ipamorelin — Per-mg Price Comparison. Retrieved July 6, 2026, from https://peptidebase.io/peptides/compare/cjc-1295/ipamorelin